The global Multiple Myeloma Therapeutics Market was valued at USD 7.5 billion in 2015 and is expected to reach a value of USD 37.5 billion by 2024. Key factors driving the market expansion include constant introduction of newer and effective therapeutic options and high adoption rates of the same.

This space is expected to gain momentum with the addition of novel drugs to the current therapeutics array with monoclonal antibodies and Histone Deacetylase (HDAC) inhibitors. Due to failed outcomes of the currently available medication, there is a high demand for effective treatment strategies to offset therapeutic dissatis faction and increase life expectancies of patients; which in turn is expected to boost the research and development of improved therapies for multiple myeloma.

Growing prevalence of the disease along with the surging elderly population is the prime factor expected to drive the growth significantly during the forecast period. Complications involved in treating geriatric patients are driving the demand for supportive treatments such as restoration procedures involving transfusion of blood components and point of care technologies.

The U.S, followed by Europe, has been dominating the market owing to the presence of major players in these regions, faster approval rates, and favorable healthcare policies. Higher prevalence of multiple myeloma in the developed economies is a pivotal determinant driving the growth of the Europe market.

The space consists of a few major players including Celgene Corporation, Janssen Biotech, Inc., Bristol-Myers Squibb Company, and Novartis AG. A large revenue share is captured by Celgene Corporation with its high-performing drug, Revlimid. The drug currently dominates the market with more than 50% share of the total multiple myeloma therapeutics market.

Related Reading @ Immunotherapy: Promising Treatment Option For Multiple Myeloma

Further Key Findings from the Study Suggest:

• According to the National Cancer Institute, more than 30,330 new cases of multiple myelomaare expected to register in 2016. The number of new cases is expected to grow each year with the growing geriatric population.
• Newly introduced drugs are expected to increase the longevity of patients undergoing treatment for multiple myeloma, which yields a high cumulative number of patients requiring treatment each year.
• In 2015, the chemotherapy and other drugs segment dominated the global space with largest revenue share owing to lack of effective alternative option.
• Chemotherapy and other drugs segment has been sub-segmented into traditional chemotherapy, immunomodulating agents, protea some inhibitors, HDAC inhibitors, and monoclonal antibodies.
• In 2015, immunomodulating agents drug class captured the largest market share. Absence of comparable alternatives is the prime factor driving the growth of the segment
• The newly introduced drugs belonging to the classes HDAC inhibitors and monoclonal antibodies are expected to show the fastest growth during the forecast period owing to the effectiveness and safety of these drugs

What Is Lenalid capsules (Lenalidomide)?

Lenalid holds Lenalidomide, which refers to a group of medicines which affect how your immune system works.

Lenalidomide is a cancer medicine and is recognized by its brand name, Revlimid.

Lenalid is a treatment for myeloma and blood disorders called myelodysplastic symptoms. You may also have it as part of clinical analyses for other types of cancer.

For myeloma, you have lenalidomide with a steroid drug called dexamethasone. Or with a chemotherapy medicine called melphalan and dexamethasone.

Read More>>

What is lenalidomide used for? Lenalidomide is used to handle various types of cancers. It works by reducing or stopping the growth of cancer cells. Lenalid is also used to manage anemia (a lack of red blood cells) in patients with myelodysplastic symptoms created by an unusual chromosome. This disease is also called deletion 5q MDS. In people with this disease, the bone marrow does not generate sufficient healthy blood cells. Lenalidomide 10 mg is also used to handle mantle cell lymphoma, follicular lymphoma, or marginal zone lymphoma. Lenalidomide is not prescribed for the treatment of a particular type of cancer (chronic lymphocytic leukemia) because of the raised risk of serious heart-related side effects and death. If you have this type of cancer, talk to your doctor about the dangers of using Lenalid.

Boosting the Red Cells in Multiple myeloma using Lenalid (Lenalidomine) Capsules

Lenalid (Lenalidomide) is one of the most popular brands in India and also in the international market treatment of Multiple myeloma. you can also find the Strength of Lenalid 5mg, Lenalid 10mg, Lenalid 15mg, Lenalid 25mg Manufactured by Natco Pharma Ltd. and contains the active ingredient Lenalidomide.

What Is Lenalid (Lenalidomide)? What Is It Used For?

Lenalid 25mg is used in the treatment of myelodysplastic syndrome, a group of blood disorders characterized by immature cells. It is also used to treat multiple myeloma (bone marrow cancer), either in combination with dexamethasone or after stem cell transplant.

Lenalid including the active ingredient lenalidomide is admitted an immunomodulating agent. It changes the way the immune system works to help the bone marrow create normal blood cells and destroying abnormal cells in the bone marrow. The tablets can be used individually or in combination with other medication to treat anemia in patients with myelodysplastic syndromes and multiple myeloma.

What is lenalidomide used for

What is it prescribed for?

• Multiple Myeloma

Lenalid is used in a mixture with dexamethasone to treat multiple myeloma, a type of blood cancer.

• What is Multiple Myeloma?

Multiple myeloma is cancer that occurs in a type of white blood cell called a plasma cell. These cells help you fight infections by making antibodies that identify and attack bacteria.

Multiple myeloma causes cancer cells to grow in the bone marrow, where they push out healthy blood cells. Rather than create helpful antibodies, the cancer cells produce abnormal proteins that can cause complications lenald 10mg is medicine for multiple myeloma.

• Myelodysplastic syndrome (MDS)

lenalid capsules is used for the treatment of patients suffering from transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndrome associated with a deletion of 5q cytogenetic abnormality with or without additional cytogenic abnormalities.

Lenalid (Lenalidomide) side effects

Chest pain

Dry mouth

Fever

Increased thirst

Cough

Bleeding gums

Nausea

Sore throat

Unusual tiredness or weakness

Vomiting

What Precautions need to take before Using Lenalid 10mg?

• Do not take Lenalid 25mg if you are allergic to anything in it.
• Tell your doctor about all of your medical conditions, including if you are pregnant or breastfeeding. Lenalidomide 10mg should not be used by women who are pregnant or breastfeeding.
• Tell your doctor about all the medicines you take covering - prescription and non-prescription drugs, vitamins, and herbal supplements. It is possible that lenalidomide 10 mg and other drugs may affect the other person triggering serious side effects.
• Know the medicines you take. Preserve a set of those to show your healthcare service provider and pharmacist.
• Take Lenalid 10mg exactly as prescribed. You must flow all the instructions of your doctor.
• In the event you neglect a dose of Lenalid 25mg, take it about the same as soon as you remember in mind. If you miss your dosage for per day, do not take double or multiple doses at the same time return to taking your regular dose the next day.
• You will have to undertake regular blood vessels tests, as approved by your healthcare provider, on your treatment with Lenalid. The healthcare provider may adapt your dose of Lenalid or temporarily stop your treatment depending on the results of your blood tests and on your overall condition.

Lenalidomide (Lenalid 10mg) mechanism of action

Lenalid helps the bone marrow to produce normal blood cells and kills the abnormal cells.

Lenalid is derived from thalidomide and is used for treating multiple myeloma and other cancers. It works in double mechanism mainly-in vitro and in vivo. In in vitro, tumor cells are disrupted from growing, angiogenesis is prevented and stimulates immunomodulation. In vivo, tumor cells are killed where bone marrow stromal cell support is inhibited and maintaining osteoclastogenic effects. Lenalid refers to a class of immunomodulatory drugs

How to use Lenalid Capsule

• Take lenalid in the dose and term as prescribed by your doctor.
• Take it as a whole.
• Do not chew, crush or break it.
• Lenalid 25mg may be taken with or without food, but it is better to take it at a decided time.

Where to Buy Lenalid?

In our suggestion, you should check your prescribed to Lenalid 5mg from AllDayGeneric online drug store which can be the same as you near the pharmacy store. Our company AllDayGeneric is a trustworthy and highly reliable name in the pharmaceutical industry and provides the top quality OTC medications and other healthcare products at an extremely reasonable cost.

A few good reasons why you should buy Lenalid from Alldaygeneric

• Buy Lenalid 5mg, 10mg, 15mg or 25mg from AllDayGeneric get 10 % off And Free Shipping on all above $199.
• We offer the quickest of the turnaround, low priced products, genuine medications at the most affordable cost.
• Our team is looking forward to serving you as our organization strives to provide with the top quality products and best in class shopping experience.